Flupenthixol Decanoate in Methamphetamine Smoking - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Substance-Related Disorders

Treatments: Drug: Flupenthixol

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000241

NIDA-07200-1

R01-07200-1

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.

Sex: All

Ages: 22 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.